Outsourcing Formulation Development & Manufacturing: Going Beyond the Science to Become True Partners

Contract Development and Manufacturing Organizations (CDMOs) are critical partners for pharma and biotech companies when it comes to providing innovative solutions that advance the next generations of therapies. To that end, CDMOs are seeking to modify contracts to maintain competitiveness and maximize revenue growth. The top three contract modification priorities are adding more indices, extending contract durations, and ensuring adaptability to shifting market requirements.

Beginning on page 36 of this edition of Drug Development & Delivery, Terry Ernest, Director of Manufacturing Science and Technology, Almac Pharma Services, explains how Almac are positioned as a specialized and flexible CDMO partner across a range of formulations.